The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy
Open accessAbstract
Several chronic viral infections (such as HIV and hepatitis C virus) are highly prevalent and are a serious health risk. The adaptation of animal viruses to the human host, as recently exemplified by influenza viruses and the severe acute respiratory syndrome coronavirus, is also a continuous threat. There is a high demand, therefore, for new antiviral lead compounds and novel therapeutic concepts. In this Review, an original therapeutic concept for suppressing enveloped viruses is presented that is based on a specific interaction of carbohydrate-binding agents (CBAs) with the glycans present on viral-envelope glycoproteins. This approach may also be extended to other pathogens, including parasites, bacteria and fungi.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J., & Hendrickson, W. A. (1998) · Nature · doi:10.1038/31405 · Cited by 2,964
DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
Geijtenbeek, T. B. H., Kwon, D. S., Torensma, R., van Vliet, S. J., van Duijnhoven, G. C. F., Middel, J., Cornelissen, I. L. M. H. A., Nottet, H. S. L. M., KewalRamani, V. N., Littman, D. R., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)80694-7 · Cited by 2,447
Antibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421
Intracellular Functions of N-Linked Glycans
Helenius, A., & Aebi, A. M. (2001) · Science · doi:10.1126/science.291.5512.2364 · Cited by 2,405
Geijtenbeek, T. B. H., Torensma, R., van Vliet, S. J., van Duijnhoven, G. C. F., Adema, G. J., van Kooyk, Y., & Figdor, C. G. (2000) · Cell · doi:10.1016/s0092-8674(00)80693-5 · Cited by 1,700
Immunology of hepatitis B virus and hepatitis C virus infection
Rehermann, B., & Nascimbeni, M. (2005) · Nature Reviews Immunology · doi:10.1038/nri1573 · Cited by 1,627
Glycosylation and the Immune System
Rudd, P. M., Elliott, T., Cresswell, P., Wilson, I. A., & Dwek, R. A. (2001) · Science · doi:10.1126/science.291.5512.2370 · Cited by 1,588
Trkola, A., Purtscher, M., Muster, T., Ballaun, C., Buchacher, A., Sullivan, N., Srinivasan, K., Sodroski, J., Moore, J. P., & Katinger, H. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.1100-1108.1996 · Cited by 1,114
Mycobacteria Target DC-SIGN to Suppress Dendritic Cell Function
Geijtenbeek, T. B. H., van Vliet, S. J., Koppel, E. A., Sanchez-Hernandez, M., Vandenbroucke-Grauls, C. M. J. E., Appelmelk, B., & van Kooyk, Y. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021229 · Cited by 1,061
Leonard, C. K., Spellman, M. W., Riddle, L., Harris, R. J., Thomas, J. N., & Gregory, T. J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)86956-3 · Cited by 985
DC-SIGN: escape mechanism for pathogens
van Kooyk, Y., & Geijtenbeek, T. B. H. (2003) · Nature Reviews Immunology · doi:10.1038/nri1182 · Cited by 928
DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells
Tassaneetrithep, B., Burgess, T. H., Granelli-Piperno, A., Trumpfheller, C., Finke, J., Sun, W., Eller, M. A., Pattanapanyasat, K., Sarasombath, S., Birx, D. L., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021840 · Cited by 890
Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
Calarese, D. A., Scanlan, C. N., Zwick, M. B., Deechongkit, S., Mimura, Y., Kunert, R., Zhu, P., Wormald, M. R., Stanfield, R. L., Roux, K. H., et al. (2003) · Science · doi:10.1126/science.1083182 · Cited by 781
Smits, H. H., Engering, A., van der Kleij, D., de Jong, E. C., Schipper, K., van Capel, T. M. M., Zaat, B. A. J., Yazdanbakhsh, M., Wierenga, E. A., & van Kooyk, Y. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.03.036 · Cited by 766
Structural Basis for Selective Recognition of Oligosaccharides by DC-SIGN and DC-SIGNR
Feinberg, H., Mitchell, D. A., Drickamer, K., & Weis, W. I. (2001) · Science · doi:10.1126/science.1066371 · Cited by 676
Scanlan, C. N., Pantophlet, R., Wormald, M. R., Saphire, E. O., Stanfield, R., Wilson, I. A., Katinger, H., Dwek, R. A., Rudd, P. M., & Burton, D. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7306-7321.2002 · Cited by 665
C-Type Lectins DC-SIGN and L-SIGN Mediate Cellular Entry by Ebola Virus in cis and in trans
Alvarez, C. P., Lasala, F., Carrillo, J., Muñiz, O., Corbí, A. L., & Delgado, R. (2002) · Journal of Virology · doi:10.1128/jvi.76.13.6841-6844.2002 · Cited by 652
DC-SIGN Is the Major Mycobacterium tuberculosis Receptor on Human Dendritic Cells
Tailleux, L., Schwartz, O., Herrmann, J.-L., Pivert, E., Jackson, M., Amara, A., Legres, L., Dreher, D., Nicod, L. P., Gluckman, J. C., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021468 · Cited by 643
Langerin is a natural barrier to HIV-1 transmission by Langerhans cells
de Witte, L., Nabatov, A., Pion, M., Fluitsma, D., de Jong, M. A. W. P., de Gruijl, T., Piguet, V., van Kooyk, Y., & Geijtenbeek, T. B. H. (2007) · Nature Medicine · doi:10.1038/nm1541 · Cited by 633
Boyd, M. R., Gustafson, K. R., McMahon, J. B., Shoemaker, R. H., O'Keefe, B. R., Mori, T., Gulakowski, R. J., Wu, L., Rivera, M. I., Laurencot, C. M., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1521 · Cited by 605
Dendritic-cell interactions with HIV: infection and viral dissemination
Wu, L., & KewalRamani, V. N. (2006) · Nature Reviews Immunology · doi:10.1038/nri1960 · Cited by 574
A role for carbohydrates in immune evasion in AIDS
Reitter, J. N., Means, R. E., & Desrosiers, R. C. (1998) · Nature Medicine · doi:10.1038/nm0698-679 · Cited by 558
Sanders, R. W., Venturi, M., Schiffner, L., Kalyanaraman, R., Katinger, H., Lloyd, K. O., Kwong, P. D., & Moore, J. P. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7293-7305.2002 · Cited by 553
Mori, T., O'Keefe, B. R., Sowder, R. C., Bringans, S., Gardella, R., Berg, S., Cochran, P., Turpin, J. A., Buckheit, R. W., McMahon, J. B., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411122200 · Cited by 445
Appelmelk, B. J., van Die, I., van Vliet, S. J., Vandenbroucke-Grauls, C. M. J. E., Geijtenbeek, T. B. H., & van Kooyk, Y. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.1635 · Cited by 431
Glycosylation: Heterogeneity and the 3D Structure of Proteins
Rudd, P. M., & Dwek, R. A. (1997) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239709085144 · Cited by 424
Marzi, A., Gramberg, T., Simmons, G., Möller, P., Rennekamp, A. J., Krumbiegel, M., Geier, M., Eisemann, J., Turza, N., Saunier, B., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.12090-12095.2004 · Cited by 377
Cambi, A., Gijzen, K., de Vries, I. J. M., Torensma, R., Joosten, B., Adema, G. J., Netea, M. G., Kullberg, B., Romani, L., & Figdor, C. G. (2003) · European Journal of Immunology · doi:10.1002/immu.200310029 · Cited by 374
Antivirals and antiviral strategies
Clercq, E. D. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro975 · Cited by 370
Halary, F., Amara, A., Lortat-Jacob, H., Messerle, M., Delaunay, T., Houlès, C., Fieschi, F., Arenzana-Seisdedos, F., Moreau, J.-F., & Déchanet-Merville, J. (2002) · Immunity · doi:10.1016/s1074-7613(02)00447-8 · Cited by 356
West Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular Attachment and Infection
Davis, C. W., Nguyen, H.-Y., Hanna, S. L., Sánchez, M. D., Doms, R. W., & Pierson, T. C. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1290-1301.2006 · Cited by 354
Parodi, A. J. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3480001 · Cited by 341
Bergman, M. P., Engering, A., Smits, H. H., van Vliet, S. J., van Bodegraven, A. A., Wirth, H.-P., Kapsenberg, M. L., Vandenbroucke-Grauls, C. M. J. E., van Kooyk, Y., & Appelmelk, B. J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041061 · Cited by 332
van Die, I. (2003) · Glycobiology · doi:10.1093/glycob/cwg052 · Cited by 316
Handbook of plant lectins : properties and biomedical applications
Damme, E. J. M. V. (1998) · Cited by 313
N-glycan processing in ER quality control
Ruddock, L. W., & Molinari, M. (2006) · Journal of Cell Science · doi:10.1242/jcs.03225 · Cited by 300
Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12
Calarese, D. A., Lee, H.-K., Huang, C.-Y., Best, M. D., Astronomo, R. D., Stanfield, R. L., Katinger, H., Burton, D. R., Wong, C.-H., & Wilson, I. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505763102 · Cited by 294
Keyaerts, E., Vijgen, L., Pannecouque, C., Van Damme, E., Peumans, W., Egberink, H., Balzarini, J., & Van Ranst, M. (2007) · Antiviral Research · doi:10.1016/j.antiviral.2007.03.003 · Cited by 294
Self-citationSpecificity of DC‐SIGN for mannose‐ and fucose‐containing glycans
van Liempt, E., Bank, C. M. C., Mehta, P., Garcı´a-Vallejo, J. J., Kawar, Z. S., Geyer, R., Alvarez, R. A., Cummings, R. D., Kooyk, Y. V., & van Die, I. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.10.009 · Cited by 286
Solution structure of cyanovirin-N, a potent HIV-inactivating protein
Bewley, C. A., Gustafson, K. R., Boyd, M. R., Covell, D. G., Bax, A., Clore, G. M., & Gronenborn, A. M. (1998) · Nature Structural Biology · doi:10.1038/828 · Cited by 265
Balzarini, J., Neyts, J., Schols, D., Hosoya, M., Van Damme, E., Peumans, W., & De Clercq, E. (1992) · Antiviral Research · doi:10.1016/0166-3542(92)90038-7 · Cited by 242
Self-citationOligosaccharide and Glycoprotein Microarrays as Tools in HIV Glycobiology
Adams, E. W., Ratner, D. M., Bokesch, H. R., McMahon, J. B., O'Keefe, B. R., & Seeberger, P. H. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.04.010 · Cited by 234
Balzarini, J., Schols, D., Neyts, J., Van Damme, E., Peumans, W., & De Clercq, E. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.3.410 · Cited by 231
Self-citationChackerian, B., Rudensey, L. M., & Overbaugh, J. (1997) · Journal of Virology · doi:10.1128/jvi.71.10.7719-7727.1997 · Cited by 207
DC-SIGN Is a Receptor for Human Herpesvirus 8 on Dendritic Cells and Macrophages
Rappocciolo, G., Jenkins, F. J., Hensler, H. R., Piazza, P., Jais, M., Borowski, L., Watkins, S. C., & Rinaldo, C. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1741 · Cited by 205
A Potent Novel Anti-HIV Protein from the Cultured Cyanobacterium Scytonema varium
Bokesch, H. R., O'Keefe, B. R., McKee, T. C., Pannell, L. K., Patterson, G. M. L., Gardella, R. S., Sowder, R. C., Turpin, J., Watson, K., Buckheit, et al. (2003) · Biochemistry · doi:10.1021/bi0205698 · Cited by 205
Lozach, P.-Y., Amara, A., Bartosch, B., Virelizier, J.-L., Arenzana-Seisdedos, F., Cosset, F.-L., & Altmeyer, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402296200 · Cited by 205
Pradimicin, a novel class of potent antifungal antibiotics.
OKI, T., KONISHI, M., TOMATSU, K., TOMITA, K., SAITOH, K.-I., TSUNAKAWA, M., NISHIO, M., MIYAKI, T., & KAWAGUCHI, H. (1988) · The Journal of Antibiotics · doi:10.7164/antibiotics.41.1701 · Cited by 186
Microbicide drug candidates to prevent HIV infection
Balzarini, J., & Van Damme, L. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60202-5 · Cited by 184
Self-citationBotos, I., O’Keefe, B. R., Shenoy, S. R., Cartner, L. K., Ratner, D. M., Seeberger, P. H., Boyd, M. R., & Wlodawer, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205909200 · Cited by 183
Progress and obstacles in the development of an AIDS vaccine
Letvin, N. L. (2006) · Nature Reviews Immunology · doi:10.1038/nri1959 · Cited by 176
Cyanovirin-N Inhibits Hepatitis C Virus Entry by Binding to Envelope Protein Glycans
Helle, F., Wychowski, C., Vu-Dac, N., Gustafson, K. R., Voisset, C., & Dubuisson, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602431200 · Cited by 175
Yang, F., Bewley, C. A., Louis, J. M., Gustafson, K. R., Boyd, M. R., Gronenborn, A. M., Clore, G. M., & Wlodawer, A. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2693 · Cited by 174
Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus
Barrientos, L. G., O’Keefe, B. R., Bray, M., Sanchez, A., Gronenborn, A. M., & Boyd, M. R. (2003) · Antiviral Research · doi:10.1016/s0166-3542(02)00183-3 · Cited by 169
Measles Virus Targets DC-SIGN To Enhance Dendritic Cell Infection
de Witte, L. D., Abt, M., Schneider‐Schaulies, S., van Kooyk, Y., & Geijtenbeek, T. B. H. (2006) · Journal of Virology · doi:10.1128/jvi.80.7.3477-3486.2006 · Cited by 162
Koppel, E. A., van Gisbergen, K. P. J. M., Geijtenbeek, T. B. H., & van Kooyk, Y. (2004) · Cellular Microbiology · doi:10.1111/j.1462-5822.2004.00480.x · Cited by 160
Hepatitis C Virus Targets DC-SIGN and L-SIGN To Escape Lysosomal Degradation
Ludwig, I. S., Lekkerkerker, A., Depla, E., Bosman, F., Musters, R. J. P., Depraetere, S., van Kooyk, Y., & Geijtenbeek, T. B. H. (2004) · Journal of Virology · doi:10.1128/jvi.78.15.8322-8332.2004 · Cited by 151
Bolmstedt, A. J., O’Keefe, B. R., Shenoy, S. R., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.949 · Cited by 150
Inhibition of HIV entry by carbohydrate-binding proteins
Balzarini, J. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.02.004 · Cited by 147
Self-citationSolution Structure of a Cyanovirin-N:Manα1-2Manα Complex
Bewley, C. A. (2001) · Structure · doi:10.1016/s0969-2126(01)00653-0 · Cited by 138
Database Analysis of O-Glycosylation Sites in Proteins
Christlet, T. H. T., & Veluraja, K. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)76074-2 · Cited by 137
New antifungal antibiotics, benanomicins A and B from an Actinomycete.
TAKEUCHI, T., HARA, T., NAGANAWA, H., Okada, M., HAMADA, M., UMEZAWAT, H., Gomi, S., Sezaki, M., & Kondo, S. (1988) · The Journal of Antibiotics · doi:10.7164/antibiotics.41.807 · Cited by 125
Carbohydrate-binding Agents Cause Deletions of Highly Conserved Glycosylation Sites in HIV GP120
Balzarini, J. M., Laethem, K. V., Hatse, S., Froeyen, M., Peumans, W. J., Damme, E. J. M. V., & Schols, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508801200 · Cited by 122
Self-citationBalzarini, J. M. (2007) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020701800101 · Cited by 109
Self-citationJohnson, W. E., Sanford, H. B., Schwall, L. R., Burton, D. R., Parren, P. W. H. I., Robinson, J. E., & Desrosiers, R. C. (2003) · Journal of Virology · doi:10.1128/jvi.77.18.9993-10003.2003 · Cited by 109
Izquierdo-Useros, N., Blanco, J., Erkizia, I., Fernández-Figueras, M. T., Borràs, F. E., Naranjo-Gómez, M., Bofill, M., Ruiz, L., Clotet, B., & Martinez-Picado, J. (2007) · Journal of Virology · doi:10.1128/jvi.02572-06 · Cited by 108
A General Model for the Surface Glycoproteins of HIV and Other Retroviruses
Gallaher, W. R., Ball, J. M., Garry, R. F., MARTIN-AMEDEE, A. M., & Montelaro, R. C. (1995) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1995.11.191 · Cited by 104
Balzarini, J. M., Laethem, K. V., Daelemans, D., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01404-06 · Cited by 104
Self-citationMeyer, S., van Liempt, E., Imberty, A., van Kooyk, Y., Geyer, H., Geyer, R., & van Die, I. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507100200 · Cited by 103
Bulgheresi, S., Schabussová, I., Chen, T., Mullin, N. P., Maizels, R. M., & Ott, J. A. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.72.4.2950-2956.2006 · Cited by 103
Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIV
Balzarini, J. M. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70271-1 · Cited by 102
Self-citationProfile of Resistance of Human Immunodeficiency Virus to Mannose-Specific Plant Lectins
Balzarini, J. M., Laethem, K. V., Hatse, S., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.19.10617-10627.2004 · Cited by 102
Self-citationStructural studies of algal lectins with anti-HIV activity.
Ziolkowska, N. E., & Wlodawer, A. (2006) · Acta Biochimica Polonica · doi:10.18388/abp.2006_3290 · Cited by 99
Role of the Mannose‐Binding Lectin in Innate Immunity
Ezekowitz, R. A. B. (2003) · The Journal of Infectious Diseases · doi:10.1086/374746 · Cited by 98
Witvrouw, M., Fikkert, V., Hantson, A., Pannecouque, C. C., O’Keefe, B. R., McMahon, J. B., Stamatatos, L., Clercq, E. D., & Bolmstedt, A. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7777-7784.2005 · Cited by 98
Viral Escape by Selection of Cytotoxic T Cell–Resistant Variants in Influenza a Virus Pneumonia
Price, G. E., Ou, R., Jiang, H., Huang, L., & Moskophidis, D. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.11.1853 · Cited by 97
Proteins that bind high-mannose sugars of the HIV envelope
Botos, I., & Wlodawer, A. (2004) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2004.05.001 · Cited by 96
Orientation of Bound Ligands in Mannose-binding Proteins
Ng, K. K.-S., Kolatkar, A. R., Park-Snyder, S., Feinberg, H., Clark, D. A., Drickamer, K., & Weis, W. I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200493200 · Cited by 93
Balzarini, J. M., Laethem, K. V., Peumans, W. J., Damme, E. J. M. V., Bolmstedt, A. J., Gago, F., & Schols, D. (2006) · Journal of Virology · doi:10.1128/jvi.00369-06 · Cited by 93
Self-citationGroot, F., van Capel, T. M. M., Schuitemaker, J. H. N., Berkhout, B., & de Jong, E. C. (2006) · Retrovirology · doi:10.1186/1742-4690-3-52 · Cited by 92
Boggiano, C., Manel, N., & Littman, D. R. (2007) · Journal of Virology · doi:10.1128/jvi.01661-06 · Cited by 81 · cited 1×
“77 and Wang et al.”
Hester, G., & Wright, C. S. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0532 · Cited by 81
Balzarini, J. M., Herrewege, Y. V., Vermeire, K., Vanham, G., & Schols, D. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.030155 · Cited by 79
Self-citationCarbohydrate recognition systems in autoimmunity
Buzás, E. I., Buzás, E. I., György, B., Buzás, E. I., György, B., Pásztói, M., Jelinek, I., Falus, A., & Gabius, H. (2006) · Autoimmunity · doi:10.1080/08916930601061470 · Cited by 77
Defensins: natural anti-HIV peptides.
Chang, T. L.-Y., & Klotman, M. E. (2004) · PubMed · Cited by 71
Yamaguchi, M., Ogawa, T., Muramoto, K., Kamio, Y., Jimbo, M., & Kamiya, H. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1749 · Cited by 66
Crystal Structures of the HIV-1 Inhibitory Cyanobacterial Protein MVL Free and Bound to Man3GlcNAc2
Williams, D. C., Lee, J. Y., Cai, M., Bewley, C. A., & Clore, G. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504642200 · Cited by 65
Balzarini, J. M., Laethem, K. V., Hatse, S., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.005082 · Cited by 65
Self-citationSerrano‐Gómez, D., Leal, J. A., & Corbí, A. L. (2005) · Immunobiology · doi:10.1016/j.imbio.2005.05.011 · Cited by 64
Puryear, W. B., Gnanakaran, S., Foley, B. T., Doria‐Rose, N. A., Korber, B., & Haigwood, N. L. (2005) · Journal of Virology · doi:10.1128/jvi.80.2.999-1014.2006 · Cited by 64
Antiviral activity of carbohydrate-binding agents against Nidovirales in cell culture
van der Meer, F. J. U. M., de Haan, C. A. M., Schuurman, N., Haijema, B. J., Peumans, W. J., Damme, E. J. M. V., Delputte, P., Balzarini, J. M., & Egberink, H. F. (2007) · Antiviral Research · doi:10.1016/j.antiviral.2007.04.003 · Cited by 63
Self-citationCD4 Coexpression Regulates DC-SIGN-Mediated Transmission of Human Immunodeficiency Virus Type 1
Wang, J., Janas, A. M., Olson, W. J., KewalRamani, V. N., & Wu, L. J. (2006) · Journal of Virology · doi:10.1128/jvi.01970-06 · Cited by 62
Wang, J., Kong, J., Li, W., Molchanova, V. I., Владимировна, Ч. И., Belogortseva, N., Lukyanov, P. A., & Zheng, Y. (2005) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2005.10.019 · Cited by 60
Baribaud, F., Doms, R. W., & Pöhlmann, S. (2002) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.6.4.423 · Cited by 59
Müller, W. E. G., Renneisen, K., Kreuter, M. H., Schröder, H. C., & Winkler, I. (1988) · PubMed · Cited by 57
Turville, S. G., Vermeire, K., Balzarini, J. M., & Schols, D. (2005) · Journal of Virology · doi:10.1128/jvi.79.21.13519-13527.2005 · Cited by 52
Self-citationHoshino, H., Seki, J., & TAKEUCHI, T. (1989) · The Journal of Antibiotics · doi:10.7164/antibiotics.42.344 · Cited by 51
Modified HIV envelope proteins with enhanced binding to neutralizing monoclonal antibodies
Kang, S., Quan, F., Huang, C., et al. (2004) · Virology · doi:10.1016/j.virol.2004.10.005 · Cited by 50
Pradimicin A inhibition of human immunodeficiency virus: Attenuation by mannan
Tanabe-Tochikura, A., Tochikura, T. S., Yoshida, O., OKI, T., & Yamamoto, N. (1990) · Virology · doi:10.1016/0042-6822(90)90016-k · Cited by 48
Ueki, T., OKA, M., FUKAGAWA, Y., & OKI, T. (1993) · The Journal of Antibiotics · doi:10.7164/antibiotics.46.465 · Cited by 47
Role of the C-type lectins DC-SIGN and L-SIGN in Leishmania interaction with host phagocytes
Caparrós, E., Serrano‐Gómez, D., Puig‐Kröger, A., Riol‐Blanco, L., Lasala, F., Martinez, I. A., Vidal‐Vanaclocha, F., Delgado, R. B., Rodríguez‐Fernández, J. L., Rivas, L., et al. (2005) · Immunobiology · doi:10.1016/j.imbio.2005.05.013 · Cited by 45
Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12
Huskens, D., Laethem, K. V., Vermeire, K., et al. (2006) · Virology · doi:10.1016/j.virol.2006.10.027 · Cited by 43
DC-SIGN specifically recognizes Streptococcus pneumoniae serotypes 3 and 14
Koppel, E. A., Saeland, E., de Cooker, D. J. M., van Kooyk, Y., & Geijtenbeek, T. B. H. (2005) · Immunobiology · doi:10.1016/j.imbio.2005.05.014 · Cited by 43
Bolmstedt, A. J., Hinkula, J., Rowcliffe, E., Biller, M., Wahrén, B., & Olofsson, S. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00358-9 · Cited by 39
Balzarini, J. M. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.04.039 · Cited by 24
Self-citationAdhesion Molecules in Leukocyte Endothelial Interaction
Etzioni, A. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4613-0415-9_17 · Cited by 12
Dendritic cell-mediated HIV-1 transmission
Groot, F. (2006) · UvA-DARE (University of Amsterdam) · Cited by 2
Cited by
Identification of host proteins required for HIV infection through a functional genomic screen
Brass, A. L., Dykxhoorn, D. M., Benita, Y., Yan, N., Engelman, A., Xavier, R. J., Lieberman, J., & Elledge, S. J. (2008) · Science · doi:10.1126/science.1152725 · Cited by 1,449
Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?
Mehellou, Y., & De Clercq, E. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm900492g · Cited by 368
A simple and accessible synthetic lectin for glucose recognition and sensing
Ke, C., Destecroix, H., Crump, M. P., & Davis, A. P. (2012) · Nature Chemistry · doi:10.1038/nchem.1409 · Cited by 278
Bitter-sweet symphony: glycan–lectin interactions in virus biology
Van Breedam, W., Pöhlmann, S., Favoreel, H. W., de Groot, R. J., & Nauwynck, H. J. (2014) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12052 · Cited by 141
Mannose receptor is an HIV restriction factor counteracted by Vpr in macrophages
Lubow, J., Virgilio, M. C., Merlino, M., Collins, D. R., Mashiba, M., Peterson, B. G., Lukic, Z., Painter, M. M., Gomez-Rivera, F., Terry, V., et al. (2020) · eLife · doi:10.7554/elife.51035 · Cited by 35
Metadata
- Authors
- Balzarini, J.
- Venue
- Nature Reviews Microbiology
- Published
- 2007-08
- Volume
- 5
- Issue
- 8
- Pages
- 583-597
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W1996641092
- Cited by
- 283
- References
- 107
- FWCI
- 0.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.